Connecting people

“ENMC goes on: Workshop applications can now be submitted to and may take place as hybrid or full virtual meetings”

Welcome to ENMC

Most neuromuscular disorders are rare (orphan) diseases, meaning that fewer than 1 in 2000 people are affected. They all cause a weakening of muscles, which could lead to tremendous disability. Because of this, international collaboration is extremely important to accelerate our knowledge and discovery of new medicines in the field of neuromuscular diseases.

Read more

ENMC reviews workshop applications bi-annually

Submission deadlines: 1 March and 1 September 2022

Guidelines how to provide care to neuromuscular patients who are affected by Covid-19:

Update to WMS advice Covid-19 and Deconfinement  (May 12 2020)

Link to the WMS advice on Vaccines (Dec 23, 2020)

Go to the translations

This is ENMC at a glance:

Most recent news

Covid-19 and people with neuromuscular disorders

28 March 2020 The World Muscle Society Position and Advice for…

ENMC White Paper

On Rare Disease Day 2020, the outcomes and consensus from the…

ENMC Mission Statement

“The mission of ENMC is to encourage and facilitate communication and collaboration in the field of neuromuscular research with the aim of improving diagnosis and prognosis, finding effective treatments and optimising standards of care to improve the quality of life of people affected by neuromuscular disorders.”